Recent research has shown enhanced expression of GSDMD in atherosclerosis, where it can mediate the cGAS/STING/TBK1/IRF3/NF-κB signaling pathway, contributing to the process of atherosclerosis. This evidence concerns the gene NFKB1 and atherosclerosis.